NKGen Biotech Statistics
Total Valuation
NKGen Biotech has a market cap or net worth of $25.60 million. The enterprise value is $53.61 million.
Important Dates
The next estimated earnings date is Tuesday, April 15, 2025.
| Earnings Date | Apr 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NKGen Biotech has 44.95 million shares outstanding. The number of shares has increased by 250.53% in one year.
| Current Share Class | 44.95M |
| Shares Outstanding | 44.95M |
| Shares Change (YoY) | +250.53% |
| Shares Change (QoQ) | +10.18% |
| Owned by Insiders (%) | 9.73% |
| Owned by Institutions (%) | 12.75% |
| Float | 22.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | -0.37 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02
| Current Ratio | 0.02 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.28 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -106.85% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 87.85% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.40M |
| Employee Count | 63 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NKGen Biotech has paid $7,000 in taxes.
| Income Tax | 7,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -54.80% in the last 52 weeks. The beta is 0.48, so NKGen Biotech's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | -54.80% |
| 50-Day Moving Average | 0.55 |
| 200-Day Moving Average | 0.76 |
| Relative Strength Index (RSI) | 52.49 |
| Average Volume (20 Days) | 10,427,079 |
Short Selling Information
The latest short interest is 520,972, so 1.16% of the outstanding shares have been sold short.
| Short Interest | 520,972 |
| Short Previous Month | 561,272 |
| Short % of Shares Out | 1.16% |
| Short % of Float | 2.30% |
| Short Ratio (days to cover) | 2.30 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -31.42M |
| Pretax Income | -80.01M |
| Net Income | -88.25M |
| EBITDA | -30.23M |
| EBIT | -31.42M |
| Earnings Per Share (EPS) | -$4.35 |
Full Income StatementBalance Sheet
The company has $79,000 in cash and $28.09 million in debt, giving a net cash position of -$28.01 million or -$0.62 per share.
| Cash & Cash Equivalents | 79,000 |
| Total Debt | 28.09M |
| Net Cash | -28.01M |
| Net Cash Per Share | -$0.62 |
| Equity (Book Value) | -69.72M |
| Book Value Per Share | -2.71 |
| Working Capital | -50.16M |
Full Balance SheetCash Flow
| Operating Cash Flow | -21.54M |
| Capital Expenditures | n/a |
| Free Cash Flow | -21.54M |
| FCF Per Share | -$0.48 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |